Counterpoint Mutual Funds’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,998
Closed -$805K 425
2025
Q1
$805K Buy
+11,998
New +$874K 0.12% 67
2024
Q4
Sell
-3,119
Closed -$268K 409
2024
Q3
$268K Sell
3,119
-133
-4% -$9.93K 0.05% 167
2024
Q2
$223K Buy
+3,252
New +$215K 0.05% 147
2023
Q1
Sell
-3,012
Closed -$146K 460
2022
Q4
$146K Sell
3,012
-3,318
-52% -$159K 0.15% 143
2022
Q3
$215K Buy
+6,330
New +$240K 0.52% 44
2022
Q2
Sell
-2,569
Closed -$85K 319
2022
Q1
$85K Buy
2,569
+1,738
+209% +$57.7K 0.07% 65
2021
Q4
$23K Buy
+831
New +$24.2K 0.02% 147

Other funds holding SLVM

Counterpoint Mutual Funds's SLVM Position: Q2 2025 in Review

Counterpoint Mutual Funds sold out of Sylvamo (SLVM) in Q2 2025, closing a stake of 11,998 shares — an estimated $805K sold.

Counterpoint Mutual Funds first reported a position in SLVM in Q4 2021 and held it in 7 quarters. The position peaked at $805K in Q1 2025. 374 funds tracked by Wall St. Rank hold SLVM as of Q2 2025.

  • Counterpoint Mutual Funds reported no remaining Sylvamo position as of Q2 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 11,998 Sylvamo shares in Q2 2025, an estimated $805K.
  • Counterpoint Mutual Funds first reported a position in Sylvamo in Q4 2021 and held it in 7 quarters.
  • Counterpoint Mutual Funds's Sylvamo position peaked at $805K in Q1 2025.
  • 374 funds tracked by Wall St. Rank held Sylvamo as of Q2 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2025, filed 14 Jul 2025.